Lukas Hainz

By functioning as a clinician-extender, the newly announced ADVOCATE system will autonomously manage heart failure patients between scheduled office visits to improve long-term outcomes. This $62.7 million initiative, launched by the Advanced Research Projects Agency for Health, represents a

For Tim Andrews, a 66-year-old patient with Type O blood, the experiment served as a vital bridge to a human transplant after two years of exhaustive waiting. This milestone, achieved through the collaboration of researchers and surgeons at Massachusetts General Hospital, signals a pivotal shift in

Technology suppliers are currently focused on removing technical burdens to allow smaller biotech firms to access high-level efficiency and reproducibility. The biomanufacturing industry stands at a critical juncture where the simple accumulation of biological data no longer provides a competitive

The architectural integrity of the human skeleton has long been regarded as a separate domain from the intricate cognitive networks of the mind, yet emerging research suggests the spine may serve as a profound biological mirror for neurological health. A comprehensive study from Johns Hopkins

For decades, the diagnosis of X-linked retinitis pigmentosa has functioned as a slow-motion countdown toward permanent darkness, leaving thousands of young men to watch their peripheral and night vision slowly fade away without any realistic hope for medical intervention. This devastating genetic

The lifelong requirement for invasive cystoscopy surveillance places an immense physical and financial burden on patients diagnosed with recurrent bladder cancer. This burden has sparked a significant paradigm shift in how urothelial carcinoma is managed, steering the medical community away from

A critical gap exists between the backend data management improvements offered by AI and the operational realities of onboarding coordinators at busy trial sites. As pharmaceutical companies transition away from legacy Electronic Data Capture systems toward more dynamic environments, the pressure

A strategic shift in customs policy has lowered barriers for essential drugs while simultaneously protecting local producers with higher tariffs on certain goods. This dual-track approach emerges as the nation grapples with a widening trade gap that is projected by BMI, a Fitch Solutions company,

Bora Biologics has executed over 200 cGMP batches to date, including more than 60 batches dedicated specifically to commercial supply programs. This extensive experience addresses a critical challenge in modern medicine: the need for reliable, high-speed diagnostic tools that can keep pace with an

The inherent swarming motility of bacterial colonies provides a unique medium for storing information that can be analyzed using standard optical scanning rather than genomic sequencing. This technological leap, spearheaded by researchers at Columbia University, represents a shift from observing